India’s Aditya-L1 captures an unprecedented solar flare, IISc researchers unlock gene activation with mini proteins in yeast, ...

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

Ever wondered why canned soda tastes different from one in a plastic bottle? Learn how container materials impact flavor.

Throughout history, roses have been a powerful motif in love stories. A new wave of rose-infused fragrances is captivating a fresh generation, adding a modern twist to this timeless symbol.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...

Aldeyra's reproxalap faced an FDA setback but showed positive trial results, leading to a resubmitted NDA. Click here to find ...

Reproxalap, a first-in-class small-molecule modulator of reactive aldehyde species (RASP), is under review for the treatment of the signs and symptoms of dry eye disease. It works by covalently ...

Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Aldeyra Therapeutics in a ...

More information: Shuai Kong et al, Targeting aldehyde dehydrogenase ALDH3A1 increases ferroptosis vulnerability in squamous cancer, Oncogene (2025). DOI: 10.1038/s41388-025-03277-4 ...

Tryptamine psychoactive substances, such as α-methyltryptamine (AMT), are monoamine alkaloids characterized by an indole ring ...

Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research report issued on Monday,Benzinga reports. They ...